Pathology EMQ template.

Name: Hannah Huang

Theme: Immune Therapies

 

OPTION LIST

 

A	Cyclophosphamide	I	Abatacept
B	Rituximab	J	Azathioprine
C	Etanercept	K	Denosumab
D	Tocilizumab	L	Ustekinumab
E	Natalizumab	M	Adalimumab
F	Basiliximab	N
G	Cyclosporin	O
H	Mycophenolate mofetil	P

 

 

For each scenario below, choose the most appropriate answer from the list above. Each option may be used once, more than once or not at all.

 

1. Inhibits T cell activation and proliferation by blocking purine synthesis

 

 

2. Antibody inhibiting RANK ligand

 

 

3. Antibody specific for CD25 and is given before and after transplantation

 

 

4. Inhibits T cell migration and used in active remitting/relapsing MS

 

 

5. Anti-TNF alpha antibody used to treat inflammatory bowel disease

 

 

 

ANSWERS

1. J

2. K

3. F

4. E

5. M